Fig. 2From: Serum superoxide dismutase level is a potential biomarker of disease prognosis in patients with HEV-induced liver failureHEV-induced liver failure patients are associated with high plasma SOD levels. A SOD levels in progression stage of ALF (p-ALF) and ACLF (p-ACLF) were significantly higher compared with healthy controls or AVH patients; B In the remission stage of ALF (r-ALF) and ACLF (r-ACLF), SOD levels were decreased. **P < 0.01Back to article page